Although international companies invest on universal solutions for individualized patient dosimetry in brachytherapy (i.e. irrespective of energy range, site, application etc.), a review of the relative importance of shortcomings of the current TG43 based TPS for specific brachytherapy processes can reveal potential for simple, expedient solutions. Examples are inter-seed attenuation in permanent prostate implants or applicator shields. If such effects are found important for clinical outcome, semi-empirical solutions will be configured based on the experience of the research team in brachytherapy dosimetry.

 

WP10. Field review and dosimetry model development
Work in progress...
Visit our page again for results and further information.


WP11. Dosimetry model benchmarking
Work in progress...
Visit our page again for results and further information.